TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,711.15+0.27%Nasdaq 10029,530.57+0.00%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.90−0.09%NYSE:TSM$427.05+1.63%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,121.81−0.46%Brent$108.97−0.23%BTC$82,652.41+0.99%ETH$2,446.75+1.73%DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,711.15+0.27%Nasdaq 10029,530.57+0.00%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.90−0.09%NYSE:TSM$427.05+1.63%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,121.81−0.46%Brent$108.97−0.23%BTC$82,652.41+0.99%ETH$2,446.75+1.73%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Coya Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › COYA

C

Coya Therapeutics Inc

NAS:COYAHealthcarenasdaq_composite

$4.28+1.84%LiveIn session · ≈ AED 15.71 · Market cap $100.33M · Next earnings Wed 11 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+1.8%

1M

−14.1%

3M

−7.7%

6M

−15.8%

1Y

−33.3%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

COYA +1.84% today

✦ This week in three lines

No written digest yet for COYA. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR —

Valuation

P/E vs sector−4.6× vs −1.7×

Price / Book vs sector2.3× vs 2.0×

Price / Sales vs sector12.4× vs 3.9×

Price / Free cash flow vs sector−9.2× vs −1.5×

Forecasts

7 buy0 hold0 sell7 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 84 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All COYA news →

TRCoya to start open-label extension of ALSTARS Phase 2/3 for COYA 302, delays FTD trial to 2027

TradingView · 6 d ago

TRCoya Therapeutics, Inc. (COYA) Plans OLE for ALS Trial; FTD Trial Pushed to 2027

TradingView · 6 d ago

BUCoya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS

BusinessWire · 6 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$100.33M

P/E−4.6×

Dividend yield0.0%

52-week range$3.71 – $7.55

Avg volume (20d)140,498

Shares outstanding23,457,850

Beta0.60

Short interest6.0% of float

Next earningsWed 11 Nov

Radar Score

—

Value—

Quality—

Momentum—

Income—

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and…

Sector

Healthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

—+4.34%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

—+2.11%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

—+2.39%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

—+3.65%